NTRK2 and Huntington disease: These results suggest that at last in part of the cause of neuronal loss observed in the striatum of the HD patients could be attributed to the impairment of the BDNF/TrkB signals in the region and compensating these functions would be a promising strategy for the future treatment for HD.